Key result
Higher LAVI/LA strain linked to ~48% higher mortality in preserved LVEF.
Why the study?
Adverse outcomes remain common in individuals with preserved LVEF, motivating the evaluation of LAVI/LA strain, a composite index integrating left atrial structural and functional remodeling, for risk stratification.
Does the LAVI/LA strain composite index improve risk stratification for all-cause mortality in individuals with preserved LVEF?
Cohort (n=466)
Does the LAVI/LA strain composite index improve risk stratification for all-cause mortality in individuals with preserved LVEF?
In individuals with preserved LVEF, the composite index of LAVI/LA strain independently predicts all-cause mortality and offers modest incremental prognostic value over standard clinical and echocardiographic models.
Answers are grounded in this paper and cite their sources.
May refine risk stratification in preserved EF; leaves open prospective validation before clinical adoption.
BACKGROUND: Adverse outcomes remain common in individuals with preserved left ventricular ejection fraction (LVEF). We evaluated left atrial volume index (LAVI)/LA strain, a composite index integrating LA structural and functional remodeling. METHODS: We retrospectively enrolled 466 participants with LVEF ≥50%. The primary endpoint was all-cause mortality; cardiovascular mortality was an exploratory secondary endpoint. Prognostic associations and incremental performance were assessed using Cox regression, 5-year time-dependent receiver operating characteristic analysis, Harrell's C, likelihood-ratio testing, bootstrap cross-validation, and competing-risk analysis. RESULTS: Among 466 participants, 90 (19.3%) died, including 28 (6.0%) cardiovascular deaths. LAVI/LA strain was independently associated with all-cause mortality after full adjustment (HR 1.475, 95% CI 1.172-1.857; p < 0.001). Adding LAVI/LA strain increased the 5-year AUC from 0.859 to 0.877 versus the clinical model (p = 0.028) and yielded a higher AUC than the clinical + E/e' model (0.877 vs. 0.863; p = 0.042). Adding LAVI/LA strain to the clinical + E/e' model also improved model fit (LRT p = 0.047). For cardiovascular mortality, the age- and sex-adjusted HR was 1.784 (95% CI 1.395-2.280; p < 0.001), with a similar Fine-Gray estimate (sHR 1.803, 95% CI 1.473-2.207; p < 0.001). CONCLUSIONS: LAVI/LA strain was independently associated with all-cause mortality in individuals with preserved LVEF and provided modest incremental prognostic information beyond clinical factors. Cardiovascular mortality findings were consistent in exploratory competing-risk analyses.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) conducted a cohort in Preserved left ventricular ejection fraction (n=466). Left atrial volume index (LAVI)/LA strain vs. Clinical model and clinical + E/e' model was evaluated on All-cause mortality (HR 1.475, 95% CI 1.172-1.857, p=<0.001). LAVI/LA strain was independently associated with all-cause mortality in individuals with preserved LVEF.
Synapse has enriched 10 related papers. Consider them for comparative context: